Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cabergoline-related severe restrictive mitral regurgitation.

Literature DB >> 16267335

Cabergoline-related severe restrictive mitral regurgitation.

Antonio Pinero, Pedro Marcos-Alberca, Jose Fortes.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 16267335 DOI： 10.1056/NEJM200511033531822

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies.

Authors: Miguel-Angel Maciá-Martínez; Francisco J de Abajo; Gilly Roberts; Jim Slattery; Bharat Thakrar; Antoni F Z Wisniewski
Journal: Drug Saf Date: 2016-01 Impact factor: 5.606

2. Risk of heart failure associated with dopamine agonists: a nested case-control study.

Authors: P H Hsieh; F Y Hsiao
Journal: Drugs Aging Date: 2013-09 Impact factor: 3.923

3. Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.

Authors: Laurent Vroonen; Patrizio Lancellotti; Monica Tomé Garcia; Raluca Dulgheru; Matilde Rubio-Almanza; Ibrahima Maiga; Julien Magne; Patrick Petrossians; Renata Auriemma; Adrian F Daly; Albert Beckers
Journal: Endocrine Date: 2016-10-05 Impact factor: 3.633

4. Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.

Authors: Gianluca Trifirò; M Mostafa Mokhles; Jeanne P Dieleman; Eva M van Soest; Katia Verhamme; Giampiero Mazzaglia; Ron Herings; Cynthia de Luise; Douglas Ross; Guy Brusselle; Annamaria Colao; Wilhelm Haverkamp; Rene Schade; Guy van Camp; Renzo Zanettini; Miriam C Sturkenboom
Journal: Drug Saf Date: 2012-02-01 Impact factor: 5.606

Review 5. Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review.

Authors: Malcolm Steiger; W Jost; F Grandas; G Van Camp
Journal: J Neural Transm (Vienna) Date: 2009-01-14 Impact factor: 3.575

Cabergoline-related severe restrictive mitral regurgitation.

1. An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies.

2. Risk of heart failure associated with dopamine agonists: a nested case-control study.

3. Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.

4. Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.

Review 5. Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review.

6. Cabergoline-induced tricuspid regurgitation: Case report and review of literature.

Review 7. Dopamine receptors and Parkinson's disease.

8. Cabergoline Effectively Induced Remission of Prolactinoma in a 9-year-old Japanese Boy.

9. Giant Prolactinoma Presenting With Facial Nerve Palsy and Hemiparesis.

10. Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.